A new method of preparation of pyocyanin and demonstration of an unusual bacterial sensitivity.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMID 115327)

Published in Anal Biochem on May 01, 1979

Authors

M Knight, P E Hartman, Z Hartman, V M Young

Articles citing this

Mechanism of the antibiotic action pyocyanine. J Bacteriol (1980) 3.00

Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J Clin Pathol (1999) 1.54

Phenazines and other redox-active antibiotics promote microbial mineral reduction. Appl Environ Microbiol (2004) 1.50

Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest (1989) 1.44

Antibiotic action of pyocyanin. Antimicrob Agents Chemother (1981) 1.44

Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun (1993) 1.42

In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments. Infect Immun (1983) 1.36

Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun (1986) 1.30

Nitric oxide is inactivated by the bacterial pigment pyocyanin. Biochem J (1990) 1.29

The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct. Biochem J (1993) 1.19

In vitro effect of synthetic pyocyanine on neutrophil superoxide production. Infect Immun (1987) 1.04

Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin. J Immunol (2008) 1.01

Inhibitory and stimulatory effects of Pseudomonas aeruginosa pyocyanine on human T and B lymphocytes and human monocytes. Infect Immun (1990) 0.99

Electrospray mass-spectrometric, spectrophotometric and electrochemical methods do not provide evidence for the binding of nitric oxide by pyocyanine at pH 7. Biochem J (1997) 0.97

Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95

Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin. Int J Exp Pathol (2008) 0.87

Production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by human neutrophils is inhibited by Pseudomonas aeruginosa phenazine derivatives. Infect Immun (1991) 0.86

Effect of pyocyanin on a crude-oil-degrading microbial community. Appl Environ Microbiol (2004) 0.85

Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br J Pharmacol (1994) 0.85

Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro. Antimicrob Agents Chemother (1992) 0.81

Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infect Immun (1997) 0.81

Standardized chemical synthesis of Pseudomonas aeruginosa pyocyanin. MethodsX (2014) 0.79

Pyocyanin production by Pseudomonas aeruginosa confers resistance to ionic silver. Antimicrob Agents Chemother (2014) 0.75

Articles by these authors

A proposal for a uniform nomenclature in bacterial genetics. Genetics (1966) 31.92

Linkage map of Salmonella typhimurium, edition V. Microbiol Rev (1978) 6.81

Histidine regulatory mutants in Salmonella typhimurium. I. Isolation and general properties. J Mol Biol (1966) 6.49

Classification and mapping of spontaneous and induced mutations in the histidine operon of Salmonella. Adv Genet (1971) 5.37

Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev (2001) 4.45

Histidine-requiring mutants of Escherichia coli K12. Genetics (1970) 4.25

Multiple repeat caesarean section in the UK: incidence and consequences to mother and child. A national, prospective, cohort study. BJOG (2012) 3.90

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med (1971) 3.82

Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Ann Intern Med (1973) 3.81

Glucagon therapy in acute pancreatitis. Br J Surg (1973) 3.48

Spiral Tube Assembly for High-Speed Countercurrent Chromatography: Choice of Elution Modes for Four Typical Two-Phase Solvent Systems. J Liq Chromatogr Relat Technol (2008) 3.33

Mechanisms of suppression. Adv Genet (1973) 3.32

Genetic evidence for the role of a bacterial phosphotransferase system in sugar transport. Proc Natl Acad Sci U S A (1967) 3.00

Heterogeneity in P22 transducing particles. Virology (1965) 2.95

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med (1972) 2.75

ICR-induced frameshift mutations in the histidine operon of Salmonella. J Bacteriol (1970) 2.71

Some improved methods in P22 transduction. Genetics (1974) 2.63

Improved spiral tube assembly for high-speed counter-current chromatography. J Chromatogr A (2008) 2.48

Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol (1998) 2.40

Hycanthone: a frameshift mutagen. Science (1971) 2.40

Factors associated with maternal death from direct pregnancy complications: a UK national case-control study. BJOG (2015) 2.40

The RPM1 plant disease resistance gene facilitates a rapid and sustained increase in cytosolic calcium that is necessary for the oxidative burst and hypersensitive cell death. Plant J (2000) 2.38

The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG (2013) 2.30

A fine structure map of the salmonella histidine operator-promoter. Genetics (1974) 2.28

Failed tracheal intubation in obstetric anaesthesia: 2 yr national case-control study in the UK. Br J Anaesth (2012) 2.28

Overproduction of hisH and hisF gene products leads to inhibition of cell cell division in Salmonella. Can J Microbiol (1972) 2.16

Interaction in the germfree mouse intestine of colicinogenic and colicin-sensitive microorganisms. Proc Soc Exp Biol Med (1969) 2.09

Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 2.08

Concentrations of nicotinamide nucleotide coenzymes in micro-organisms. J Gen Microbiol (1966) 2.08

Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature (1980) 2.03

Transfer RNA and the control of the histidine operon. Cold Spring Harb Symp Quant Biol (1966) 2.02

Maternal sepsis: a Scottish population-based case-control study. BJOG (2012) 1.95

The emergence of coryneform bacteria as a cause of nosocomial infections in compromised hosts. Am J Med (1981) 1.86

In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother (1972) 1.82

Promoter- and attenuator-related metabolic regulation of the Salmonella typhimurium histidine operon. J Bacteriol (1978) 1.74

Histidyl-transfer ribonucleic acid synthetase in positive control of the histidine operon in Salmonella typhimurium. J Bacteriol (1974) 1.67

Pseudomonas aeruginosa in a center for cancer research. I. Distribution of intraspecies types from human and environmental sources. J Infect Dis (1972) 1.63

Effects of mechanical signaling on plant cell cytosolic calcium. Proc Natl Acad Sci U S A (1995) 1.63

Control of the ppp(a2'p)nA system in HeLa cells. Effects of interferon and virus infection. Eur J Biochem (1982) 1.61

Recovery of more than 1 organism in septicemias. N Engl J Med (1965) 1.60

Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet (1998) 1.58

Comparison of killing of gram-negative and gram-positive bacteria by pure singlet oxygen. J Bacteriol (1989) 1.57

The impact of maternal obesity on intrapartum outcomes in otherwise low risk women: secondary analysis of the Birthplace national prospective cohort study. BJOG (2013) 1.56

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med (1975) 1.53

Ultraviolet susceptibility of BCG and virulent tubercle bacilli. Am Rev Respir Dis (1976) 1.53

Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis (1974) 1.51

Bacterial proliferation in platelet products stored at room temperature. Transfusion-induced Enterobacter sepsis. N Engl J Med (1971) 1.49

Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess (2010) 1.49

Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium. J Bacteriol (1976) 1.48

Mechanical signalling, calcium and plant form. Plant Mol Biol (1994) 1.47

Physical association of starch biosynthetic enzymes with starch granules of maize endosperm. Granule-associated forms of starch synthase I and starch branching enzyme II. Plant Physiol (1996) 1.46

Eclampsia, a comparison within the International Network of Obstetric Survey Systems. BJOG (2014) 1.45

Evaluation of a multitest system for identification of saccharolytic pseudomonads. Am J Clin Pathol (1978) 1.43

Constant observation: implications for nursing practice. J Psychosoc Nurs Ment Health Serv (1995) 1.42

Septicemia due to Mycoplasma hominis type 1. N Engl J Med (1965) 1.40

Chemotaxis of Salmonella typhimurium to amino acids and some sugars. J Bacteriol (1978) 1.36

Experiences with maternal and perinatal death reviews in the UK--the MBRRACE-UK programme. BJOG (2014) 1.36

Ergothioneine as antioxidant. Methods Enzymol (1990) 1.34

The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity. Ann Intern Med (1974) 1.33

A computerized system for clinical microbiology. Am J Clin Pathol (1972) 1.31

Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents. Antimicrob Agents Chemother (1978) 1.31

Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer. Am J Med (1979) 1.31

Microtiter bacterial hemagglutination technique for detection of Shigella antibodies. J Bacteriol (1966) 1.29

Infection in acute leukemia patients receiving oral nonabsorable antibiotics. Antimicrob Agents Chemother (1978) 1.27

Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. JAMA (1976) 1.25

Pseudomonas septicemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer. Eur J Cancer (1973) 1.21

A proposal for a uniform nomenclature in bacterial genetics. J Gen Microbiol (1968) 1.20

Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization. Am J Med (1976) 1.20

Pure singlet oxygen cytotoxicity for bacteria. Photochem Photobiol (1987) 1.20

Standardization of absolute CD4+ lymphocyte counts across laboratories: an evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry (1995) 1.18

The antiviral action of interferon. Philos Trans R Soc Lond B Biol Sci (1982) 1.18

A computerized data storage and retrieval system for clinical microbiology. Am J Clin Pathol (1974) 1.18

Export of glutathione by some widely used Salmonella typhimurium and Escherichia coli strains. J Bacteriol (1986) 1.17

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med (1981) 1.15

Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ (2001) 1.14

Zinc attenuates tumor necrosis factor-mediated activation of transcription factors in endothelial cells. J Am Coll Nutr (1997) 1.14

Relationship of colonization with Pseudomonas aeruginosa to development of Pseudomonas bacteremia in cancer patients. Antimicrob Agents Chemother (Bethesda) (1970) 1.13

Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia. Antimicrob Agents Chemother (1981) 1.13

Direct selection for transduction of suppressor mutations and linkage of supD to fla genes in Salmonella. J Bacteriol (1971) 1.12

Pneumonia in acute leukemia. Ann Intern Med (1973) 1.12

Virus-mediated inhibition of the ppp(A2'p)nA system and its prevention by interferon. Biochem Biophys Res Commun (1982) 1.10

Salmonella typhimurium peptidase active on carnosine. J Bacteriol (1978) 1.09

Genetics of Biomphalaria glabrata and its effect on the outcome of Schistosoma mansoni infection. Parasitol Today (1992) 1.08

Effect of varying preincubation and diffusion times on antibiotic disc susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1965) 1.08

Isolation and characterization of the zSSIIa and zSSIIb starch synthase cDNA clones from maize endosperm. Plant Mol Biol (1998) 1.08

Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemiologic, preventive and therapeutic research. Am J Med (1981) 1.08

Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients. Antimicrob Agents Chemother (1976) 1.08

In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients. Antimicrob Agents Chemother (1980) 1.06

Sugar transport by the bacterial phosphotransferase system. Isolation and characterization of a phosphocarrier protein HPr from wild type and mutants of Salmonella typhimurium. J Biol Chem (1982) 1.06

Diagnosis of enterobacteriaceae in the hospital laboratory. Am J Clin Pathol (1966) 1.06

Multiple modes of photodynamic action by cercosporin. Photochem Photobiol (1988) 1.06

Esophagoscopy as a source of Pseudomonas aeruginosa sepsis in patients with acute leukemia: the need for sterilization of endoscopes. Gastroenterology (1974) 1.04

Hycanthone analogs: dissociation of mutagenic effects from antischistosomal effects. Science (1974) 1.04

The bacterial oxidation of picolinamide, a photolytic product of Diquat. Biochem J (1972) 1.02

Deletions fusing the hisG and hisD genes in Salmonella typhimurium. J Bacteriol (1975) 1.02

Serotyping of Pseudomonas aeruginosa. J Infect Dis (1974) 1.02

The bacterial degradation of flavonoids. Hydroxylation of the A-ring of taxifolin by a soil pseudomonad. Biochem J (1972) 1.01